Structural vaccinology expedites rational design of next-generation vaccines for influenza and respiratory syncytial virus
Authors:
Open Access
- 1 April 2026
- journal article
- review article
- Published by KEAI Publishing in Virologica Sinica
- Vol. 41 (2) , 261-275
Abstract
Vaccination stands as the single most effective and cost-efficient public health intervention in human history, serving as a cornerstone of modern medicine that profoundly transforms global health outcomes. Beyond preventing disease, it acts as a catalyst for equitable socioeconomic development. In recent decades, recurrent seasonal viral outbreaks and sporadic yet catastrophic pandemics, have continued to pose challenges to global public health systems. Traditional vaccine technologies, however, not only often fall short in protection efficacy, but also fail to keep pace with the evolving demands of next-generation vaccine development. These scientific gaps have directed cutting-edge research to prioritize critical objectives in terms of enhancing antigen effectiveness, achieving stable pan-protection against diverse variant strains, and strengthening production robustness. The advent of genomics spurred the emergence of reverse vaccinology 1.0, leading to breakthroughs like the MenB vaccine. Today, the advanced reverse vaccinology 2.0 paradigm thoroughly redefines vaccine design process by organically integrating human immunology with state-of-the-art computational protein structure analysis tools. This review explores the transformative shifts in influenza and respiratory syncytial virus vaccine development, along with specific case studies, to deepen understanding of the evolving principles and methodologies in novel vaccine designs and offer strategic insights for addressing emerging infectious pathogens.Keywords
Funding Information
- Hunan University
- National Key Research and Development Program of China (2025YFC2311703)
This publication has 237 references indexed in Scilit:
- Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Lower Respiratory Tract DiseaseJAMA Network Open, 2024
- Nanovaccines Displaying the Influenza Virus Hemagglutinin in an Inverted Orientation Elicit an Enhanced Stalk‐Directed Antibody ResponseAdvanced Healthcare Materials, 2023
- Nirsevimab: First ApprovalDrugs, 2022
- An overview of influenza A virus genes, protein functions, and replication cycle highlighting important updatesVirus Genes, 2022
- Vaccine Design by Reverse Vaccinology and Machine Learning2021
- Neutralizing antibody PR8‐23 targets the footprint of the sialoglycan receptor binding site of H1N1 hemagglutininJournal of Medical Virology, 2021
- Genome-Based Bacterial Vaccines: Current State and Future OutlookBioDrugs, 2013
- Fine antigenic variation within H5N1 influenza virus hemagglutinin's antigenic sites defined by yeast cell surface displayEuropean Journal of Immunology, 2009
- D. A. Henderson: Smallpox. The Death of a Disease. The Inside Story of Eradicating a Worldwide KillerJournal of Community Health, 2009
- Effect of Proteolytic Processing at Two Distinct Sites on Shape and Aggregation of an Anchorless Fusion Protein of Human Respiratory Syncytial Virus and Fate of the Intervening SegmentVirology, 2002